Trademark Attorney / Law Firm

Francis Kalinski – Trademark Portfolio

Francis Kalinski specializes in Class 44 (Medical Services) trademark filings before the United States Patent and Trademark Office (USPTO), with 4 of 7 total filings concentrated in this category. The practice also covers Class 25 (Clothing) along with 3 other Nice Classification classes. Filing activity spans from 2016 to 2018. Currently, 0 trademarks are registered.

7 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Francis Kalinski's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

25
Clothing (2 filings)

Clothing, footwear, headgear

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademark applications has Francis Kalinski filed?

Francis Kalinski has filed 7 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Francis Kalinski specialize in?

Francis Kalinski has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 44 (Medical Services), Class 25 (Clothing), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

How long has Francis Kalinski been filing trademarks?

Francis Kalinski's trademark filing history with the USPTO spans from 2016 to 2018, covering 2 years of trademark practice. During this period, Francis Kalinski has handled 7 trademark applications.

What is Francis Kalinski's trademark registration success rate?

Francis Kalinski has a 0% trademark registration rate, with 0 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.